CAM
RGNX icon

Cresset Asset Management’s Regenxbio RGNX Stock Holding History

Cresset Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,731
Closed -$374K – 2162
2024
Q1 		$374K Buy
17,731
+306
+2% +$5.45K ﹤0.01% 1477
2023
Q4 		$313K Buy
17,425
+75
+0.4% +$1.32K ﹤0.01% 1471
2023
Q3 		$286K Buy
17,350
+80
+0.5% +$1.45K ﹤0.01% 1454
2023
Q2 		$345K Buy
+17,270
New +$333K ﹤0.01% 1461
2022
Q1 		– Sell
-10,847
Closed -$354K – 1116
2021
Q4 		$354K Buy
+10,847
New +$369K ﹤0.01% 818
2019
Q2 		– Sell
-61
Closed -$3K – 1412
2019
Q1 		$3K Buy
+61
New +$3.02K ﹤0.01% 1538

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return